FDA recall classifications are based on patient risk. Which statement correctly describes Class I, Class II, and Class III recalls?

• A. Class I: serious risk of death or serious health problems; Class II: temporary or reversible adverse health problems or risk of serious health problems; Class III: not likely to cause adverse health effects.
• B. Class I indicates a remote risk of adverse health effects; Class II indicates a serious risk; Class III indicates a high risk.
• C. Class I: minor adverse effects; Class II: moderate adverse effects; Class III: no adverse effects.
• D. Class I: no action required; Class II: recall is optional; Class III: voluntary only.

Answer: (B)

Recall classifications reflect how seriously patient health could be affected. The highest level is used when use or exposure is reasonably likely to cause death or serious health problems. The middle level covers adverse effects that are temporary or reversible, or a remote possibility of serious harm. The lowest level is for issues not likely to cause adverse health effects. The statement that flips these risk levels—making Class I a remote risk and Class II the serious risk, with Class III as high risk—does not align with FDA definitions. The correct framework is: Class I = serious risk of death or serious health problems; Class II = temporary or reversible adverse effects (or remote risk of serious harm); Class III = not likely to cause adverse health effects.